|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of Tumors of the Central Nervous System: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Geiger GA, Fu W and Kao GD:
Temozolomide-mediated radiosensitization of human glioma cells in a
zebrafish embryonic system. Cancer Res. 68:3396–3404. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng Y, Lin L and Zheng Z: TGF-alpha
induces upregulation and nuclear translocation of Hes1 in glioma
cell. Cell Biochem Funct. 26:692–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng H, Ying H, Wiedemeyer R, Yan H,
Quayle SN, Ivanova EV, Paik JH, Zhang H, Xiao Y, Perry SR, et al:
PLAGL2 regulates Wnt signaling to impede differentiation in neural
stem cells and gliomas. Cancer Cell. 17:497–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Moor CH, Meijer H and Lissenden S:
Mechanisms of translational control by the 3′ UTR in development
and differentiation. Semin Cell Dev Biol. 16:49–58. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berezikov E, Guryev V, van de Belt J,
Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and
computational identification of human microRNA genes. Cell.
120:21–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pichler M and Calin GA: MicroRNAs in
cancer: From developmental genes in worms to their clinical
application in patients. Br J Cancer. 113:569–573. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin Z, Zhao J, Wang X, Zhu X and Gong L:
Overexpression of microRNA-497 suppresses cell proliferation and
induces apoptosis through targeting paired box 2 in human ovarian
cancer. Oncol Rep. 36:2101–2107. 2016.PubMed/NCBI
|
|
10
|
Quintavalle C, Garofalo M, Zanca C, Romano
G, Iaboni M, De del Basso Caro M, Martinez-Montero JC, Incoronato
M, Nuovo G, Croce CM, et al: miR-221/222 overexpession in human
glioblastoma increases invasiveness by targeting the protein
phosphate PTPμ. Oncogene. 31:858–868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie YK, Huo SF, Zhang G, Zhang F, Lian ZP,
Tang XL and Jin C: CDA-2 induces cell differentiation through
suppressing Twist/SLUG signaling via miR-124 in glioma. J
Neurooncol. 110:179–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Li H, Han L, Zhang K, Wang G, Wang
Y, Liu Y, Zheng Y, Jiang T, Pu P, et al: Expression and function of
miR-27b in human glioma. Oncol Rep. 26:1617–1621. 2011.PubMed/NCBI
|
|
13
|
Zheng WW, Zhou J, Zhang CH and Liu XS:
MicroRNA-216b is downregulated in hepatocellular carcinoma and
inhibits HepG2 cell growth by targeting Forkhead box protein M1.
Eur Rev Med Pharmacol Sci. 20:2541–2550. 2016.PubMed/NCBI
|
|
14
|
Korver W, Schilham MW, Moerer P, van den
Hoff MJ, Dam K, Lamers WH, Medema RH and Clevers H: Uncoupling of S
phase and mitosis in cardiomyocytes and hepatocytes lacking the
winged-helix transcription factor Trident. Curr Biol. 8:1327–1330.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu M, Dai B, Kang SH, Ban K, Huang FJ,
Lang FF, Aldape KD, Xie TX, Pelloski CE, Xie K, et al: FoxM1B is
overexpressed in human glioblastomas and critically regulates the
tumorigenicity of glioma cells. Cancer Res. 66:3593–3602. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scholzen T and Gerdes J: The Ki-67
protein: From the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
19
|
Kim SY, Lee YH and Bae YS: MiR-186,
miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular
senescence by targeting α subunit of protein kinase CKII in human
colorectal cancer cells. Biochem Biophys Res Commun. 429:173–179.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng L, Zhang X, Yang F, Zhu J, Zhou P,
Yu F, Hou L, Xiao L, He Q and Wang B: Regulation of the P2X7R by
microRNA-216b in human breast cancer. Biochem Biophys Res Commun.
452:197–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang
EL, Wu ZB, Huang ZY and Chen XP: MiR-216b is involved in
pathogenesis and progression of hepatocellular carcinoma through
HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis.
6:e16702015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Egeli U, Tezcan G, Cecener G, Tunca B,
Sevinc E Demirdogen, Kaya E, Ak S, Dundar HZ, Sarkut P, Ugras N, et
al: miR-216b targets FGFR1 and confers sensitivity to radiotherapy
in pancreatic ductal adenocarcinoma patients without EGFR or KRAS
mutation. Pancreas. 45:1294–1302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng M, Liu JF, Gu YX, Zheng GP and He ZM:
miR-216b suppresses cell proliferation and invasion by targeting
PKCα in nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi.
35:645–650. 2013.(In Chinese). PubMed/NCBI
|
|
25
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, et al: FoxM1 promotes
β-catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis. Cancer Cell. 20:427–442. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koo CY, Muir KW and Lam EW: FOXM1: From
cancer initiation to progression and treatment. Biochim Biophys
Acta. 1819:28–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu GY, Shi BZ and Li Y: FoxM1 regulates
Sirt1 expression in glioma cells. Eur Rev Med Pharmacol Sci.
18:205–211. 2014.PubMed/NCBI
|
|
28
|
Raychaudhuri P and Park HJ: FoxM1: A
master regulator of tumor metastasis. Cancer Res. 71:4329–4333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Zhang G and Kong C: FOXM1
participates in PLK1-regulated cell cycle progression in renal cell
cancer cells. Oncol Lett. 11:2685–2691. 2016.PubMed/NCBI
|
|
30
|
Luo X, Yao J, Nie P, Yang Z, Feng H, Chen
P, Shi X and Zou Z: FOXM1 promotes invasion and migration of
colorectal cancer cells partially dependent on HSPA5
transactivation. Oncotarget. 7:26480–26495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mahabir R, Tanino M, Elmansuri A, Wang L,
Kimura T, Itoh T, Ohba Y, Nishihara H, Shirato H, Tsuda M, et al:
Sustained elevation of Snail promotes glial-mesenchymal transition
after irradiation in malignant glioma. Neuro Oncol. 16:671–685.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu
M, Feng XH, Sawaya R, Medema RH, Hung MC, et al: Sustained
activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer
metastasis. J Clin Invest. 124:564–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai
MH, Liu HC, Zhang RY and Liu C: FoxM1 overexpression promotes
epithelial-mesenchymal transition and metastasis of hepatocellular
carcinoma. World J Gastroenterol. 21:196–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Chen XY, Huang KJ, Wu WD, Jiang
T, Cao J, Zhou LS, Qiu ZJ and Huang C: Expression of FoxM1 and the
EMT-associated protein E-cadherin in gastric cancer and its
clinical significance. Oncol Lett. 12:2445–2450. 2016.PubMed/NCBI
|
|
35
|
Chiu WT, Huang YF, Tsai HY, Chen CC, Chang
CH, Huang SC, Hsu KF and Chou CY: FOXM1 confers to
epithelial-mesenchymal transition, stemness and chemoresistance in
epithelial ovarian carcinoma cells. Oncotarget. 6:2349–2365. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao B, Wang Z, Ali S, Kong D, Banerjee S,
Ahmad A, Li Y, Azmi AS, Miele L and Sarkar FH: Over-expression of
FoxM1 leads to epithelial-mesenchymal transition and cancer stem
cell phenotype in pancreatic cancer cells. J Cell Biochem.
112:2296–2306. 2011. View Article : Google Scholar : PubMed/NCBI
|
